Citadel Advisors’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 6493 |
|
|
2025
Q1 | – | Sell |
-37,587
| Closed | -$120K | – | 6530 |
|
|
2024
Q4 | $120K | Buy |
37,587
+35,434
| +1,646% | +$113K | ﹤0.01% | 5098 |
|
|
2024
Q3 | $7.9K | Buy |
+2,153
| New | +$7.9K | ﹤0.01% | 5473 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6452 |
|
|
2024
Q1 | – | Sell |
-24,858
| Closed | -$106K | – | 6553 |
|
|
2023
Q4 | $106K | Sell |
24,858
-5,774
| -19% | -$24.7K | ﹤0.01% | 4853 |
|
|
2023
Q3 | $104K | Buy |
30,632
+5,895
| +24% | +$20.1K | ﹤0.01% | 4823 |
|
|
2023
Q2 | $140K | Buy |
24,737
+13,761
| +125% | +$77.6K | ﹤0.01% | 4600 |
|
|
2023
Q1 | $53K | Sell |
10,976
-8,345
| -43% | -$40.3K | ﹤0.01% | 5145 |
|
|
2022
Q4 | $117K | Buy |
19,321
+6,568
| +52% | +$39.7K | ﹤0.01% | 4951 |
|
|
2022
Q3 | $61K | Buy |
+12,753
| New | +$61K | ﹤0.01% | 5259 |
|
|
2022
Q1 | – | Sell |
-11,095
| Closed | -$89K | – | 6793 |
|
|
2021
Q4 | $89K | Buy |
+11,095
| New | +$89K | ﹤0.01% | 5959 |
|
|
2021
Q2 | – | Sell |
-11,192
| Closed | -$203K | – | 6786 |
|
|
2021
Q1 | $203K | Buy |
+11,192
| New | +$203K | ﹤0.01% | 5396 |
|